APR 30, 2015 10:10 AM PDT

Key Moment in Stem Cell Growth Brought to Light

WRITTEN BY: Judy O'Rourke
Stem cells, which have the prospect of turning into any kind of cell, offer the alluring possibility of generating new tissues for organ replacements, stroke victims, and patients of many other diseases. Scientists at the Salk Institute, La Jolla, Calif, have uncovered details about stem cell growth that could help improve regenerative therapies.

While it was known that two key cellular processes-called Wnt and Activin-were needed for stem cells to grow into specific mature cells, no one knew exactly how these pathways worked together.
In early-stage cell nuclei (blue), developmental genes (green) must be turned on for the cell to develop. When the two cellular processes, Wnt and Activin, work together (upper left), genes are activated to a much greater degree than when neither process is active (upper right). When just a single pathway is active (Wnt, lower left, Activin, lower right), only a few genes are turned on.
The details of how Wnt and Activin influence each other offer guidance for improving stem cell therapies. The Salk researchers' findings are in an article titled "SMADs and YAP Compete to Control Elongation of β-Catenin:LEF-1-Recruited RNAPII during hESC Differentiation," published April 30, 2015 in the journal Molecular Cell.

The new work also reveals more about certain cancers that arise when these processes go astray, for example, when the Wnt signaling step becomes inappropriately reactivated, as happens in most colon cancers.

"We found that the mechanisms of these two pathways are complementary and activate the transcription, or turning on, of about 200 genes essential for stem cells to differentiate," says Kathy Jones, senior author of the paper and a Salk professor. These genes are among the first steps that prompt stem cells to begin to change, or differentiate, into specific tissues, particularly ones that will eventually form the digestive and respiratory tracts, including intestines, lung, pancreas, thyroid, and liver.

The researchers found that Wnt loads up the cellular machinery needed to begin the copying and activation of genes. Activin, meanwhile, boosts the process further: it increases the speed and efficiency by which the cellular machinery moves to copy the gene. Whereas Wnt treatment alone enhances the expression of developmental genes by a factor of 20-fold, further treatment with Activin boosts the signal to 150-fold or higher, says Jones. The team also found that the order of the signaling is equally important, because Activin could not turn on these genes unless the cells were first exposed to the Wnt signal.

"Wnt gets the ball rolling and Activin amplifies the signal," says Conchi Estarás, first author of the paper. "This is a particularly clear example of how two different pathways, working through two different mechanisms, can cooperate to activate the same genes." The new finding adds to a growing picture that the transcription process is much more dynamic than previous thought.

"Now we understand stem cell differentiation at a much finer level by seeing how these cellular signals transmit their effects in the cells," Jones says. "Understanding these details is important for developing more robust stem cell protocols and optimizing the efficiency of stem cell therapies."

When they looked closer at the genes that both pathways activated, researchers were surprised to find that the pathways were further connected to a third process, which is known to control tissue growth and organ size. The central protein in this new pathway, called Yap, acted specifically at these genes to counteract the effects of the Activin.

"The opposing effects of Activin and Yap are exerted at a late step in transcription, the elongation phase," Jones says. "We don't know very much about the signaling networks in normal or cancer cells specifically affect the elongation stage of transcription, so it was a real bonus to find that it is targeted by two pathways in stem cells."

Both the Wnt and Activin signaling processes operate differently in cancer, compared to stem cells. Wnt, in particular, is turned on very early in human colon cancer in nearly 90 percent of cases. The aberrant behavior of the Activin process, meanwhile, is tied to the metastasis of many cancers.

"There is great interest in developing transcription-based inhibitors of the Wnt pathway, because these would have strong anticancer activity for many tumor types," Estarás says. "Because the environment of stem cells and cancer cells are quite distinct, and different target genes are involved, it will be interesting to see how the synergy and regulation that we have defined in stem cells operates in the cells of a tumor."

[Source: Salk Institute for Biological Studies]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
MAR 15, 2020
Genetics & Genomics
MAR 15, 2020
Insight Into Neuronal Growth and Memory Formation
Now scientists have learned more about the transport of mRNA in neurons, and the storage and formation of memories.
MAR 17, 2020
Cell & Molecular Biology
MAR 17, 2020
In Search of the Original Enzyme
It has been suggested that life arose from molecules that gradually came together in the right ways to form simple cells ...
APR 06, 2020
Cancer
APR 06, 2020
A New Lead in the Treatment of Hepatocellular Carcinomas
  Hepatocellular carcinoma, or HCC, is a type of liver cancer, and the third most prevalent cancer-caused death in ...
APR 02, 2020
Cancer
APR 02, 2020
Diagnosing Cancer: SMOC2 and Thyroid Cancer
  Thyroid cancer is the most common of the endocrine cancers, with papillary thyroid carcinomas (PTCs) being the mo ...
APR 02, 2020
Chemistry & Physics
APR 02, 2020
How Particle Physicists can Lend a Hand to the Search for SARS-CoV-02 Cure, Explained
With vaccines at least one year away and no proven treatment for infection, the world has witnessed the loss of  20 ...
MAY 29, 2020
Genetics & Genomics
MAY 29, 2020
Advances in Our Understanding of Huntington's Disease
Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded sequence in the huntingtin gene.
Loading Comments...